Alternative diagnoses in patients in whom the GP considered the diagnosis of pulmonary embolism

Fam Pract. 2014 Dec;31(6):670-7. doi: 10.1093/fampra/cmu055. Epub 2014 Sep 12.

Abstract

Introduction: Pulmonary embolism (PE) often presents with nonspecific symptoms and may be an easily missed diagnosis. When the differential diagnosis includes PE, an empirical list of frequently occurring alternative diagnoses could support the GP in diagnostic decision making.

Objectives: To identify common alternative diagnoses in patients in whom the GP suspected PE but in whom PE could be ruled out. To investigate how the Wells clinical decision rule for PE combined with a point-of-care d-dimer test is associated with these alternative diagnoses.

Methods: Secondary analysis of the Amsterdam Maastricht Utrecht Study on thrombo-Embolism (Amuse-2) study, which validated the Wells PE rule combined with point-of-care d-dimer testing in primary care. All 598 patients had been referred to and diagnosed in secondary care. All diagnostic information was retrieved from the GPs' medical records.

Results: In 516 patients without PE, the most frequent alternative diagnoses were nonspecific thoracic pain/dyspnoea (42.6%), pneumonia (13.0%), myalgia (11.8%), asthma/chronic obstructive pulmonary disease (4.8%), panic disorder/hyperventilation (4.1%) and respiratory tract infection (2.3%). Pneumonia occurred almost as frequent as PE. Patients without PE with either a positive Wells rule (>4) or a positive d-dimer test, were more often (odds ratio = 2.1) diagnosed with a clinically relevant disease than patients with a negative Wells rule and negative d-dimer test.

Conclusion: In primary care patients suspected of PE, the most common clinically relevant diagnosis other than PE was pneumonia. A positive Wells rule or a positive d-dimer test are not only positively associated with PE, but also with a high probability of other clinically relevant disease.

Keywords: Bacterial pneumonia; chest pain/dyspnoea; diagnostic decision making; differential diagnoses; primary care; pulmonary embolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifibrinolytic Agents
  • Biomarkers / blood
  • Chest Pain / diagnosis
  • Chest Pain / etiology
  • Decision Support Systems, Clinical / statistics & numerical data*
  • Diagnosis, Differential
  • Dyspnea / diagnosis
  • Dyspnea / etiology
  • Female
  • Fibrin Fibrinogen Degradation Products*
  • General Practice / methods
  • General Practice / statistics & numerical data*
  • Humans
  • Male
  • Middle Aged
  • Netherlands
  • Pneumonia / diagnosis*
  • Point-of-Care Systems / statistics & numerical data
  • Predictive Value of Tests
  • Prospective Studies
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis*
  • Respiratory Tract Diseases / diagnosis
  • Respiratory Tract Diseases / physiopathology
  • Young Adult

Substances

  • Antifibrinolytic Agents
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D